NOACs vs warfarin: an expert’s 3-minute guide

In just over 2 minutes, Associate Professor John Amerena, director of cardiology research at Barwon Health in Victoria examines the risks and benefits of NOACs versus warfarin, and explains why prescribers’ caution could have consequences for patients.